Approvals/TGA/APO-PRAMIPEXOLE pramipexole dihydrochloride monohydrate 0.125 mg tablet blister pack

Approved

STANDARD

APO-PRAMIPEXOLE pramipexole dihydrochloride monohydrate 0.125 mg tablet blister pack

Southern Cross Pharma Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 642846d690a2df56
Product Name: APO-PRAMIPEXOLE pramipexole dihydrochloride monohydrate 0.125 mg tablet blister pack
Artg Id: 227666
Artg Name: APO-PRAMIPEXOLE pramipexole dihydrochloride monohydrate 0.125 mg tablet blister pack
Sponsor: Southern Cross Pharma Pty Ltd
Company Detail Path: /organization/southern-cross-pharma-pty-ltd
Artg Date: 2015-11-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-CMI-01996-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-02750-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

642846d690a2df56

Type

Standard